Safety and Immunogenicity of 9-valent Human Papillomavirus (9vHPV) Vaccine Coadministered With Messenger Ribonucleic Acid (mRNA)-1273 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (COVID-19) Vaccine (V503-076)
Public ClinicalTrials.gov record NCT05119855. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Multicenter, Open-Label Study to Evaluate the Safety and Immunogenicity of 2-dose Regimens of 9vHPV and mRNA-1273 SARS-CoV-2 Vaccines Where the First Dose of Each Vaccine Are Given Concomitantly in Boys and Girls 9 to 11 Years of Age
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study to evaluate the safety and immunogenicity of a 2-dose regimen of 9vHPV vaccine, where the first dose is administered concomitantly with a first dose of a 2-dose regimen of mRNA-1273 vaccine versus nonconcomitant administration of 9vHPV and mRNA-1273 vaccines in boys and girls 9 to 11 years of age.
Study identification
- NCT ID
- NCT05119855
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 165 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 9 Years to 11 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 27, 2022
- Primary completion
- Dec 11, 2023
- Completion
- Dec 11, 2023
- Last update posted
- Feb 4, 2026
2022 – 2023
United States locations
- U.S. sites
- 38
- U.S. states
- 17
- U.S. cities
- 36
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Cognitive Clinical Trials, LLC ( Site 0054) | Phoenix | Arizona | 85044 | — |
| Eclipse Clinical Research ( Site 0095) | Tucson | Arizona | 85745 | — |
| Children's Clinic of Jonesboro, PA ( Site 0044) | Jonesboro | Arkansas | 72401 | — |
| Preferred Research Partners Inc. ( Site 0092) | Little Rock | Arkansas | 72211 | — |
| Coast Clinical Research, LLC ( Site 0027) | Bellflower | California | 90706 | — |
| Ark Clinical Research ( Site 0098) | Long Beach | California | 90815 | — |
| Valley Clinical Trials Inc. ( Site 0004) | Northridge | California | 91325 | — |
| Medical Center for Clinical Research ( Site 0051) | San Diego | California | 92120 | — |
| Ark Clinical Research ( Site 0108) | Tustin | California | 92780 | — |
| Emerson Clinical Research Institute ( Site 0021) | Washington D.C. | District of Columbia | 20011 | — |
| Accel Research Sites-DeLand Clinical Research Unit ( Site 0066) | DeLand | Florida | 32720 | — |
| Advanced Research for Health Improvement, LLC ( Site 0012) | Immokalee | Florida | 34142 | — |
| Acevedo Clinical Research Associates ( Site 0001) | Miami | Florida | 33142 | — |
| Alpha Science Research ( Site 0067) | Miami | Florida | 33186 | — |
| Advanced Research For Health Improvement LLC ( Site 0075) | Naples | Florida | 34102 | — |
| Comprehensive Clinical Research ( Site 0038) | West Palm Beach | Florida | 33409 | — |
| Atlanta Center for Medical Research ( Site 0055) | Atlanta | Georgia | 30331 | — |
| Mount Vernon Clinical Research ( Site 0053) | Sandy Springs | Georgia | 30328 | — |
| Clinical Research Prime ( Site 0088) | Idaho Falls | Idaho | 83404 | — |
| CBH Health ( Site 0019) | Gaithersburg | Maryland | 20877 | — |
| SKY Integrative Medical Center/SKYCRNG ( Site 0084) | Ridgeland | Mississippi | 39157 | — |
| Midwest Children's Health Research Institute ( Site 0003) | Lincoln | Nebraska | 68505 | — |
| Certified Research Associates ( Site 0090) | Cortland | New York | 13045 | — |
| Corning Center for Clinical Research ( Site 0091) | Horseheads | New York | 14845 | — |
| Carolina Institute for Clinical Research, LLC ( Site 0042) | Fayetteville | North Carolina | 28303 | — |
| M3 Wake Research, Inc. ( Site 0014) | Raleigh | North Carolina | 27612 | — |
| Dayton Clinical Research ( Site 0028) | Dayton | Ohio | 45409 | — |
| Thomas Jefferson University - Family and Community Medicine ( Site 0006) | Philadelphia | Pennsylvania | 19107 | — |
| WR-ClinSearch ( Site 0049) | Chattanooga | Tennessee | 37421 | — |
| DermResearch, Inc. ( Site 0056) | Austin | Texas | 78759 | — |
| South Texas Clinical Research ( Site 0024) | Corpus Christi | Texas | 78404 | — |
| South Texas Pediatric Research Group ( Site 0094) | Del Rio | Texas | 78840 | — |
| West Houston Clinical Research Services ( Site 0078) | Houston | Texas | 77055 | — |
| Next Level Urgent Care, LLC ( Site 0099) | Houston | Texas | 77057 | — |
| Milton Haber, M.D. ( Site 0069) | Laredo | Texas | 78041 | — |
| University of Texas Medical Branch ( Site 0026) | League City | Texas | 77573 | — |
| University of Utah ( Site 0076) | Salt Lake City | Utah | 84132 | — |
| Velocity Clinical Research, Salt Lake City ( Site 0025) | West Jordan | Utah | 84088 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05119855, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 4, 2026 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05119855 live on ClinicalTrials.gov.